Article Type
Changed
Wed, 01/17/2018 - 11:50
Display Headline
Painful red nodule on the right hand

A 46-year-old healthy man presents with a 15-day history of a tender subcutaneous nodule on the dorsum of the right hand that appeared after cleaning his aquarium. He has no fever or systemic symptoms. For 2 weeks he has been taking amoxicillin-clavulanate (Augmentin) and metronidazole (Flagyl), but without an adequate response.

Figure 1. A red nodule with central ulceration on the right hand.
Figure 2. A nodule on the patient’s forearm with a sporotrichoid distribution. Locoregional lymph nodes were not palpable.
On physical examination, the nodule is painful and has central ulceration (Figure 1). Another two nodules are noted on the forearm, with a sporotrichoid distribution (Figure 2). Locoregional lymph nodes are not palpable.

Figure 3. Histologic testing revealed a mixed infiltrate with lymphocytes, neutrophils, and histiocytes (hematoxylin-eosin, × 40).
Laboratory testing (hemography, biochemistry panel, coagulation test, and C-reactive protein) are normal. Routine bacterial cultures of blood and wound drainage are repeatedly negative. Histologic study (Figure 3) reveals signs of acute and chronic inflammation (a mixed infiltrate with lymphocytes, neutrophils, and histiocytes) with abundant bacilli by Ziehl-Neelsen and Giemsa stains.

Q: Which is the most likely diagnosis?

  • Tuberculosis verrucosa cutis
  • Sporotrichosis
  • Nontuberculous mycobacterial infection
  • Leishmaniasis
  • Nocardiosis

A: The correct answer is nontuberculous mycobacterial infection. Mycobacterium marinum was subsequently isolated from culture (Löwenstein-Jensen medium) of wound drainage.

Tuberculosis verrucosa cutis is an indolent, warty plaque that occurs after direct inoculation of M tuberculosis into the skin of someone previously infected with M tuberculosis. It can result from accidental exposure to tuberculous tissue in high-risk groups such as laboratory workers, physicians, and pathologists.

Sporothrix schenckii is the dimorphic fungus that causes sporotrichosis. Activities associated with acquisition of sporotrichosis include gardening (rose-gardener's disease), landscaping, farming, berry-picking, horticulture, and carpentry. The characteristic infection involves suppurating subcutaneous nodules that progress proximally along lymphatic channels (lymphocutaneous sporotrichosis).

Leishmaniasis is a disease caused by the protozoa of the Leishmania species, which is transmitted by the bite of a female sandfly. Initially, the lesion is a small, red papule up to 2 cm in diameter. Over several weeks, the papule becomes darker, develops a crust in the center, and eventually ulcerates to present a typical appearance of an ulcer with raised edges and surrounding dusky red skin.

Nocardia is a genus of filamentous grampositive bacteria that stains acid-fast, just as M marinum does. Nocardia asteroides primarily affects the lungs and can disseminate systemically. However, Nocardia brasiliensis is often associated with sporotrichoid-spreading subcutaneous nodules.

CLINICAL PRESENTATION AND DIAGNOSIS

M marinum is a genus of nontuberculous mycobacteria that usually causes disease in fish but can cause human skin infection by penetrating through a break in the skin. It can spread to deeper structures, resulting in tenosynovitis, arthritis, or osteomyelitis.1 The disease caused by M marinum is sometimes called “swimming pool granuloma” or “fish-tank granuloma.”2

In this case, the patient probably acquired the infection while cleaning his home aquarium,3 so asking about contact with pet fish is very important for the clinical diagnosis.

Lesions are usually localized to the site of the inoculation, with a predilection for areas predisposed to trauma, such as the hands and the fingers, after an incubation period of 2 to 8 weeks. Lesions are self-limited and usually appear as pruriginous bluish-red papules or pustules that may increase in size to form a verrucous or violaceous plaque or nodule. Superficial lesions often undergo central ulceration. Disseminated infection is rare and occurs mainly in patients who are immunocompromised because of renal transplant, systemic lupus erythematosus, chronic steroid therapy, or anti-tumor necrosis factor alpha therapy.4 In such cases, infection can be life-threatening.

On histopathologic study, a nonspecific inflammation consisting of a mixed infiltrate with lymphocytes, neutrophils, and histiocytes is usually observed. Sometimes a granulomatous inflammatory infiltrate mimicking tuberculoid granuloma may be noted. M marinum is an aerobic, nonmotile acid-fast bacillus. It grows at 30°C to 32°C on Löwenstein-Jensen medium in 2 to 5 weeks, but cultures are rarely positive. Polymerase chain reaction and enzyme-linked immunosorbent assays can help identify the organism. Other diagnoses to be considered are leishmaniasis, tuberculosis verrucosa cutis, blastomycosis, histoplasmosis, and sporotrichosis.

TREATMENT

Treatment of M marinum infection is not based on any specific criteria. Spontaneous resolution in 24 to 36 months has been described. 5 Antibiotics are the first-line therapy, and sometimes surgical treatment may be necessary for deeper infection with necrotic tissue. Cryotherapy, electrode therapy, and irradiation have been reported to be effective.

Few studies have been conducted to determine the first-line antibiotic treatment for M marinum infection. In this case, treatment with sulfamethoxazole-trimethoprim6 (Bactrim) resulted in resolution of the lesions in 6 months. Other antibiotics often used as monotherapy are tetracycline, minocycline (Minocin), and doxycycline (Vibramycin) 100 mg twice daily for 3 months.7 However, treatment failure has been described with many antibiotics.

Multidrug therapy is usually prescribed to minimize the risk of resistance. A combination of clarithromycin (Biaxin), streptomycin, and ethionamide (Trecator) has been prescribed successfully.3 Another combined regimen—clarithromycin 500 mg twice a day, rifampin (Rifadin) 600 mg daily, and ethambutol (Myambutol) 25 mg/kg daily—has been shown to be effective.5 Also, rifampin 600 mg daily and ethambutol 15 to 25 mg/kg/day were effective in a patient with a sporotrichoid M marinum infection associated with infliximab (Remicade). 8 The duration of treatment ranged between 2 and 6 months, or up to 2 months after the disappearance of the cutaneous lesions.

Clinical awareness of M marinum infection is important so that the diagnosis can be made and appropriate therapy can be initiated promptly, because some cases with disseminated disease and serious complications have been described.9

References
  1. Lam A, Toma W, Schlesinger N. Mycobacterium marinum arthritis mimicking rheumatoid arthritis. J Rheumatol 2006; 33:817819.
  2. Lewis FM, Marsh BJ, von Reyn CF. Fish tank exposure and cutaneous infections due to Mycobacterium marinum: tuberculin skin testing, treatment, and prevention. Clin Infect Dis 2003; 37:390397.
  3. Dodiuk-Gad R, Dyachenko P, Ziv M, et al. Nontuberculous mycobacterial infections of the skin: a retrospective study of 25 cases. J Am Acad Dermatol 2007; 57:413420.
  4. Streit M, Böhlen LM, Hunziker T, et al. Disseminated Mycobacterium marinum infection with extensive cutaneous eruption and bacteremia in an immunocompromised patient. Eur J Dermatol 2006; 16:7983.
  5. Jogi R, Tyring SK. Therapy of nontuberculous mycobacterial infections. Dermatol Ther 2004; 17:491498.
  6. Alinovi A, Vecchini F, Bassissi P. Sporothricoid mycobacterial infection. A case report. Acta Derm Venereol 1993; 73:146147.
  7. Mahaisavariya P, Chaiprasert A, Khemngern S, et al. Nontuberculous mycobacterial skin infections: clinical and bacteriological studies. J Med Assoc Thai 2003; 86:5260.
  8. Rallis E, Koumantaki-Mathioudaki E, Frangoulis E, Chatziolou E, Katsambas A. Severe sporotrichoid fish tank granuloma following infliximab therapy. Am J Clin Dermatol 2007; 8:385388.
  9. Imakado S, Kojima Y, Hiyoshi T, Morimoto S. Disseminated Mycobacterium marinum infection in a patient with diabetic nephropathy. Diabetes Res Clin Pract 2009; 83:e35e36.
Article PDF
Author and Disclosure Information

Salvador Arias-Santiago, MD
Department of Dermatology, San Cecilio University Hospital, Granada, Spain

José Aneiros-Fernández, MD
Department of Pathology, San Cecilio University Hospital, Granada, Spain

Husein Husein El-Ahmed, MD
Department of Dermatology, San Cecilio University Hospital, Granada, Spain

María Sierra Girón-Prieto, MD
Department of Dermatology, San Cecilio University Hospital, Granada, Spain

Leopoldo Muñoz-Medina, PhD
Department of Internal Medicine, San Cecilio University Hospital, Granada, Spain

Ramón Naranjo-Sintes, PhD
Department of Dermatology, San Cecilio University Hospital, Granada, Spain

Address: Salvador Arias-Santiago, MD, San Cecilio University Hospital, Av Dr Olóriz 16, Granada 18012, Spain; e-mail salvadorarias@hotmail.es

Issue
Cleveland Clinic Journal of Medicine - 77(8)
Publications
Topics
Page Number
512-515
Sections
Author and Disclosure Information

Salvador Arias-Santiago, MD
Department of Dermatology, San Cecilio University Hospital, Granada, Spain

José Aneiros-Fernández, MD
Department of Pathology, San Cecilio University Hospital, Granada, Spain

Husein Husein El-Ahmed, MD
Department of Dermatology, San Cecilio University Hospital, Granada, Spain

María Sierra Girón-Prieto, MD
Department of Dermatology, San Cecilio University Hospital, Granada, Spain

Leopoldo Muñoz-Medina, PhD
Department of Internal Medicine, San Cecilio University Hospital, Granada, Spain

Ramón Naranjo-Sintes, PhD
Department of Dermatology, San Cecilio University Hospital, Granada, Spain

Address: Salvador Arias-Santiago, MD, San Cecilio University Hospital, Av Dr Olóriz 16, Granada 18012, Spain; e-mail salvadorarias@hotmail.es

Author and Disclosure Information

Salvador Arias-Santiago, MD
Department of Dermatology, San Cecilio University Hospital, Granada, Spain

José Aneiros-Fernández, MD
Department of Pathology, San Cecilio University Hospital, Granada, Spain

Husein Husein El-Ahmed, MD
Department of Dermatology, San Cecilio University Hospital, Granada, Spain

María Sierra Girón-Prieto, MD
Department of Dermatology, San Cecilio University Hospital, Granada, Spain

Leopoldo Muñoz-Medina, PhD
Department of Internal Medicine, San Cecilio University Hospital, Granada, Spain

Ramón Naranjo-Sintes, PhD
Department of Dermatology, San Cecilio University Hospital, Granada, Spain

Address: Salvador Arias-Santiago, MD, San Cecilio University Hospital, Av Dr Olóriz 16, Granada 18012, Spain; e-mail salvadorarias@hotmail.es

Article PDF
Article PDF

A 46-year-old healthy man presents with a 15-day history of a tender subcutaneous nodule on the dorsum of the right hand that appeared after cleaning his aquarium. He has no fever or systemic symptoms. For 2 weeks he has been taking amoxicillin-clavulanate (Augmentin) and metronidazole (Flagyl), but without an adequate response.

Figure 1. A red nodule with central ulceration on the right hand.
Figure 2. A nodule on the patient’s forearm with a sporotrichoid distribution. Locoregional lymph nodes were not palpable.
On physical examination, the nodule is painful and has central ulceration (Figure 1). Another two nodules are noted on the forearm, with a sporotrichoid distribution (Figure 2). Locoregional lymph nodes are not palpable.

Figure 3. Histologic testing revealed a mixed infiltrate with lymphocytes, neutrophils, and histiocytes (hematoxylin-eosin, × 40).
Laboratory testing (hemography, biochemistry panel, coagulation test, and C-reactive protein) are normal. Routine bacterial cultures of blood and wound drainage are repeatedly negative. Histologic study (Figure 3) reveals signs of acute and chronic inflammation (a mixed infiltrate with lymphocytes, neutrophils, and histiocytes) with abundant bacilli by Ziehl-Neelsen and Giemsa stains.

Q: Which is the most likely diagnosis?

  • Tuberculosis verrucosa cutis
  • Sporotrichosis
  • Nontuberculous mycobacterial infection
  • Leishmaniasis
  • Nocardiosis

A: The correct answer is nontuberculous mycobacterial infection. Mycobacterium marinum was subsequently isolated from culture (Löwenstein-Jensen medium) of wound drainage.

Tuberculosis verrucosa cutis is an indolent, warty plaque that occurs after direct inoculation of M tuberculosis into the skin of someone previously infected with M tuberculosis. It can result from accidental exposure to tuberculous tissue in high-risk groups such as laboratory workers, physicians, and pathologists.

Sporothrix schenckii is the dimorphic fungus that causes sporotrichosis. Activities associated with acquisition of sporotrichosis include gardening (rose-gardener's disease), landscaping, farming, berry-picking, horticulture, and carpentry. The characteristic infection involves suppurating subcutaneous nodules that progress proximally along lymphatic channels (lymphocutaneous sporotrichosis).

Leishmaniasis is a disease caused by the protozoa of the Leishmania species, which is transmitted by the bite of a female sandfly. Initially, the lesion is a small, red papule up to 2 cm in diameter. Over several weeks, the papule becomes darker, develops a crust in the center, and eventually ulcerates to present a typical appearance of an ulcer with raised edges and surrounding dusky red skin.

Nocardia is a genus of filamentous grampositive bacteria that stains acid-fast, just as M marinum does. Nocardia asteroides primarily affects the lungs and can disseminate systemically. However, Nocardia brasiliensis is often associated with sporotrichoid-spreading subcutaneous nodules.

CLINICAL PRESENTATION AND DIAGNOSIS

M marinum is a genus of nontuberculous mycobacteria that usually causes disease in fish but can cause human skin infection by penetrating through a break in the skin. It can spread to deeper structures, resulting in tenosynovitis, arthritis, or osteomyelitis.1 The disease caused by M marinum is sometimes called “swimming pool granuloma” or “fish-tank granuloma.”2

In this case, the patient probably acquired the infection while cleaning his home aquarium,3 so asking about contact with pet fish is very important for the clinical diagnosis.

Lesions are usually localized to the site of the inoculation, with a predilection for areas predisposed to trauma, such as the hands and the fingers, after an incubation period of 2 to 8 weeks. Lesions are self-limited and usually appear as pruriginous bluish-red papules or pustules that may increase in size to form a verrucous or violaceous plaque or nodule. Superficial lesions often undergo central ulceration. Disseminated infection is rare and occurs mainly in patients who are immunocompromised because of renal transplant, systemic lupus erythematosus, chronic steroid therapy, or anti-tumor necrosis factor alpha therapy.4 In such cases, infection can be life-threatening.

On histopathologic study, a nonspecific inflammation consisting of a mixed infiltrate with lymphocytes, neutrophils, and histiocytes is usually observed. Sometimes a granulomatous inflammatory infiltrate mimicking tuberculoid granuloma may be noted. M marinum is an aerobic, nonmotile acid-fast bacillus. It grows at 30°C to 32°C on Löwenstein-Jensen medium in 2 to 5 weeks, but cultures are rarely positive. Polymerase chain reaction and enzyme-linked immunosorbent assays can help identify the organism. Other diagnoses to be considered are leishmaniasis, tuberculosis verrucosa cutis, blastomycosis, histoplasmosis, and sporotrichosis.

TREATMENT

Treatment of M marinum infection is not based on any specific criteria. Spontaneous resolution in 24 to 36 months has been described. 5 Antibiotics are the first-line therapy, and sometimes surgical treatment may be necessary for deeper infection with necrotic tissue. Cryotherapy, electrode therapy, and irradiation have been reported to be effective.

Few studies have been conducted to determine the first-line antibiotic treatment for M marinum infection. In this case, treatment with sulfamethoxazole-trimethoprim6 (Bactrim) resulted in resolution of the lesions in 6 months. Other antibiotics often used as monotherapy are tetracycline, minocycline (Minocin), and doxycycline (Vibramycin) 100 mg twice daily for 3 months.7 However, treatment failure has been described with many antibiotics.

Multidrug therapy is usually prescribed to minimize the risk of resistance. A combination of clarithromycin (Biaxin), streptomycin, and ethionamide (Trecator) has been prescribed successfully.3 Another combined regimen—clarithromycin 500 mg twice a day, rifampin (Rifadin) 600 mg daily, and ethambutol (Myambutol) 25 mg/kg daily—has been shown to be effective.5 Also, rifampin 600 mg daily and ethambutol 15 to 25 mg/kg/day were effective in a patient with a sporotrichoid M marinum infection associated with infliximab (Remicade). 8 The duration of treatment ranged between 2 and 6 months, or up to 2 months after the disappearance of the cutaneous lesions.

Clinical awareness of M marinum infection is important so that the diagnosis can be made and appropriate therapy can be initiated promptly, because some cases with disseminated disease and serious complications have been described.9

A 46-year-old healthy man presents with a 15-day history of a tender subcutaneous nodule on the dorsum of the right hand that appeared after cleaning his aquarium. He has no fever or systemic symptoms. For 2 weeks he has been taking amoxicillin-clavulanate (Augmentin) and metronidazole (Flagyl), but without an adequate response.

Figure 1. A red nodule with central ulceration on the right hand.
Figure 2. A nodule on the patient’s forearm with a sporotrichoid distribution. Locoregional lymph nodes were not palpable.
On physical examination, the nodule is painful and has central ulceration (Figure 1). Another two nodules are noted on the forearm, with a sporotrichoid distribution (Figure 2). Locoregional lymph nodes are not palpable.

Figure 3. Histologic testing revealed a mixed infiltrate with lymphocytes, neutrophils, and histiocytes (hematoxylin-eosin, × 40).
Laboratory testing (hemography, biochemistry panel, coagulation test, and C-reactive protein) are normal. Routine bacterial cultures of blood and wound drainage are repeatedly negative. Histologic study (Figure 3) reveals signs of acute and chronic inflammation (a mixed infiltrate with lymphocytes, neutrophils, and histiocytes) with abundant bacilli by Ziehl-Neelsen and Giemsa stains.

Q: Which is the most likely diagnosis?

  • Tuberculosis verrucosa cutis
  • Sporotrichosis
  • Nontuberculous mycobacterial infection
  • Leishmaniasis
  • Nocardiosis

A: The correct answer is nontuberculous mycobacterial infection. Mycobacterium marinum was subsequently isolated from culture (Löwenstein-Jensen medium) of wound drainage.

Tuberculosis verrucosa cutis is an indolent, warty plaque that occurs after direct inoculation of M tuberculosis into the skin of someone previously infected with M tuberculosis. It can result from accidental exposure to tuberculous tissue in high-risk groups such as laboratory workers, physicians, and pathologists.

Sporothrix schenckii is the dimorphic fungus that causes sporotrichosis. Activities associated with acquisition of sporotrichosis include gardening (rose-gardener's disease), landscaping, farming, berry-picking, horticulture, and carpentry. The characteristic infection involves suppurating subcutaneous nodules that progress proximally along lymphatic channels (lymphocutaneous sporotrichosis).

Leishmaniasis is a disease caused by the protozoa of the Leishmania species, which is transmitted by the bite of a female sandfly. Initially, the lesion is a small, red papule up to 2 cm in diameter. Over several weeks, the papule becomes darker, develops a crust in the center, and eventually ulcerates to present a typical appearance of an ulcer with raised edges and surrounding dusky red skin.

Nocardia is a genus of filamentous grampositive bacteria that stains acid-fast, just as M marinum does. Nocardia asteroides primarily affects the lungs and can disseminate systemically. However, Nocardia brasiliensis is often associated with sporotrichoid-spreading subcutaneous nodules.

CLINICAL PRESENTATION AND DIAGNOSIS

M marinum is a genus of nontuberculous mycobacteria that usually causes disease in fish but can cause human skin infection by penetrating through a break in the skin. It can spread to deeper structures, resulting in tenosynovitis, arthritis, or osteomyelitis.1 The disease caused by M marinum is sometimes called “swimming pool granuloma” or “fish-tank granuloma.”2

In this case, the patient probably acquired the infection while cleaning his home aquarium,3 so asking about contact with pet fish is very important for the clinical diagnosis.

Lesions are usually localized to the site of the inoculation, with a predilection for areas predisposed to trauma, such as the hands and the fingers, after an incubation period of 2 to 8 weeks. Lesions are self-limited and usually appear as pruriginous bluish-red papules or pustules that may increase in size to form a verrucous or violaceous plaque or nodule. Superficial lesions often undergo central ulceration. Disseminated infection is rare and occurs mainly in patients who are immunocompromised because of renal transplant, systemic lupus erythematosus, chronic steroid therapy, or anti-tumor necrosis factor alpha therapy.4 In such cases, infection can be life-threatening.

On histopathologic study, a nonspecific inflammation consisting of a mixed infiltrate with lymphocytes, neutrophils, and histiocytes is usually observed. Sometimes a granulomatous inflammatory infiltrate mimicking tuberculoid granuloma may be noted. M marinum is an aerobic, nonmotile acid-fast bacillus. It grows at 30°C to 32°C on Löwenstein-Jensen medium in 2 to 5 weeks, but cultures are rarely positive. Polymerase chain reaction and enzyme-linked immunosorbent assays can help identify the organism. Other diagnoses to be considered are leishmaniasis, tuberculosis verrucosa cutis, blastomycosis, histoplasmosis, and sporotrichosis.

TREATMENT

Treatment of M marinum infection is not based on any specific criteria. Spontaneous resolution in 24 to 36 months has been described. 5 Antibiotics are the first-line therapy, and sometimes surgical treatment may be necessary for deeper infection with necrotic tissue. Cryotherapy, electrode therapy, and irradiation have been reported to be effective.

Few studies have been conducted to determine the first-line antibiotic treatment for M marinum infection. In this case, treatment with sulfamethoxazole-trimethoprim6 (Bactrim) resulted in resolution of the lesions in 6 months. Other antibiotics often used as monotherapy are tetracycline, minocycline (Minocin), and doxycycline (Vibramycin) 100 mg twice daily for 3 months.7 However, treatment failure has been described with many antibiotics.

Multidrug therapy is usually prescribed to minimize the risk of resistance. A combination of clarithromycin (Biaxin), streptomycin, and ethionamide (Trecator) has been prescribed successfully.3 Another combined regimen—clarithromycin 500 mg twice a day, rifampin (Rifadin) 600 mg daily, and ethambutol (Myambutol) 25 mg/kg daily—has been shown to be effective.5 Also, rifampin 600 mg daily and ethambutol 15 to 25 mg/kg/day were effective in a patient with a sporotrichoid M marinum infection associated with infliximab (Remicade). 8 The duration of treatment ranged between 2 and 6 months, or up to 2 months after the disappearance of the cutaneous lesions.

Clinical awareness of M marinum infection is important so that the diagnosis can be made and appropriate therapy can be initiated promptly, because some cases with disseminated disease and serious complications have been described.9

References
  1. Lam A, Toma W, Schlesinger N. Mycobacterium marinum arthritis mimicking rheumatoid arthritis. J Rheumatol 2006; 33:817819.
  2. Lewis FM, Marsh BJ, von Reyn CF. Fish tank exposure and cutaneous infections due to Mycobacterium marinum: tuberculin skin testing, treatment, and prevention. Clin Infect Dis 2003; 37:390397.
  3. Dodiuk-Gad R, Dyachenko P, Ziv M, et al. Nontuberculous mycobacterial infections of the skin: a retrospective study of 25 cases. J Am Acad Dermatol 2007; 57:413420.
  4. Streit M, Böhlen LM, Hunziker T, et al. Disseminated Mycobacterium marinum infection with extensive cutaneous eruption and bacteremia in an immunocompromised patient. Eur J Dermatol 2006; 16:7983.
  5. Jogi R, Tyring SK. Therapy of nontuberculous mycobacterial infections. Dermatol Ther 2004; 17:491498.
  6. Alinovi A, Vecchini F, Bassissi P. Sporothricoid mycobacterial infection. A case report. Acta Derm Venereol 1993; 73:146147.
  7. Mahaisavariya P, Chaiprasert A, Khemngern S, et al. Nontuberculous mycobacterial skin infections: clinical and bacteriological studies. J Med Assoc Thai 2003; 86:5260.
  8. Rallis E, Koumantaki-Mathioudaki E, Frangoulis E, Chatziolou E, Katsambas A. Severe sporotrichoid fish tank granuloma following infliximab therapy. Am J Clin Dermatol 2007; 8:385388.
  9. Imakado S, Kojima Y, Hiyoshi T, Morimoto S. Disseminated Mycobacterium marinum infection in a patient with diabetic nephropathy. Diabetes Res Clin Pract 2009; 83:e35e36.
References
  1. Lam A, Toma W, Schlesinger N. Mycobacterium marinum arthritis mimicking rheumatoid arthritis. J Rheumatol 2006; 33:817819.
  2. Lewis FM, Marsh BJ, von Reyn CF. Fish tank exposure and cutaneous infections due to Mycobacterium marinum: tuberculin skin testing, treatment, and prevention. Clin Infect Dis 2003; 37:390397.
  3. Dodiuk-Gad R, Dyachenko P, Ziv M, et al. Nontuberculous mycobacterial infections of the skin: a retrospective study of 25 cases. J Am Acad Dermatol 2007; 57:413420.
  4. Streit M, Böhlen LM, Hunziker T, et al. Disseminated Mycobacterium marinum infection with extensive cutaneous eruption and bacteremia in an immunocompromised patient. Eur J Dermatol 2006; 16:7983.
  5. Jogi R, Tyring SK. Therapy of nontuberculous mycobacterial infections. Dermatol Ther 2004; 17:491498.
  6. Alinovi A, Vecchini F, Bassissi P. Sporothricoid mycobacterial infection. A case report. Acta Derm Venereol 1993; 73:146147.
  7. Mahaisavariya P, Chaiprasert A, Khemngern S, et al. Nontuberculous mycobacterial skin infections: clinical and bacteriological studies. J Med Assoc Thai 2003; 86:5260.
  8. Rallis E, Koumantaki-Mathioudaki E, Frangoulis E, Chatziolou E, Katsambas A. Severe sporotrichoid fish tank granuloma following infliximab therapy. Am J Clin Dermatol 2007; 8:385388.
  9. Imakado S, Kojima Y, Hiyoshi T, Morimoto S. Disseminated Mycobacterium marinum infection in a patient with diabetic nephropathy. Diabetes Res Clin Pract 2009; 83:e35e36.
Issue
Cleveland Clinic Journal of Medicine - 77(8)
Issue
Cleveland Clinic Journal of Medicine - 77(8)
Page Number
512-515
Page Number
512-515
Publications
Publications
Topics
Article Type
Display Headline
Painful red nodule on the right hand
Display Headline
Painful red nodule on the right hand
Sections
Disallow All Ads
Alternative CME
Article PDF Media